Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier, Academic Press
2008
|
| Schlagworte: | |
| Online-Zugang: | Publisher description |
| Beschreibung: | Includes bibliographical references (p. 492) and index |
| Beschreibung: | XIX, 526 S. graph. Darst. 27 cm |
| ISBN: | 9780123695208 0123695201 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV023481701 | ||
| 003 | DE-604 | ||
| 005 | 20100201 | ||
| 007 | t | ||
| 008 | 080807s2008 ne d||| |||| 00||| eng d | ||
| 010 | |a 2007035586 | ||
| 020 | |a 9780123695208 |c alk. paper |9 978-0-1236-9520-8 | ||
| 020 | |a 0123695201 |c alk. paper |9 0-1236-9520-1 | ||
| 035 | |a (OCoLC)169452881 | ||
| 035 | |a (DE-599)BVBBV023481701 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a ne |c NL | ||
| 049 | |a DE-19 |a DE-29 | ||
| 050 | 0 | |a RS420 | |
| 082 | 0 | |a 615/.19 | |
| 084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
| 100 | 1 | |a Kerns, Edward Harvel |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Drug-like properties: concepts, structure design and methods |b from ADME to toxicity optimization |c Edward H. Kerns and Li Di |
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier, Academic Press |c 2008 | |
| 300 | |a XIX, 526 S. |b graph. Darst. |c 27 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. 492) and index | ||
| 650 | 4 | |a Chimie pharmaceutique | |
| 650 | 4 | |a Médicaments - Conception | |
| 650 | 4 | |a Médicaments - Développement | |
| 650 | 4 | |a Médicaments - Relations structure-activité | |
| 650 | 4 | |a Pharmaceutical chemistry | |
| 650 | 4 | |a Drugs |x Structure-activity relationships | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Drugs |x Design | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 4 | |a Drug Toxicity | |
| 650 | 4 | |a Pharmaceutical Preparations |x metabolism | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 4 | |a Structure-Activity Relationship | |
| 650 | 0 | 7 | |a Wirkungsmechanismus |0 (DE-588)4292866-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Konzeption |0 (DE-588)4204973-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 1 | |a Konzeption |0 (DE-588)4204973-8 |D s |
| 689 | 0 | 2 | |a Wirkungsmechanismus |0 (DE-588)4292866-7 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Di, Li |e Sonstige |4 oth | |
| 856 | 4 | |u http://www.loc.gov/catdir/enhancements/fy0811/2007035586-d.html |3 Publisher description | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016663813 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804137908163051520 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Kerns, Edward Harvel |
| author_facet | Kerns, Edward Harvel |
| author_role | aut |
| author_sort | Kerns, Edward Harvel |
| author_variant | e h k eh ehk |
| building | Verbundindex |
| bvnumber | BV023481701 |
| callnumber-first | R - Medicine |
| callnumber-label | RS420 |
| callnumber-raw | RS420 |
| callnumber-search | RS420 |
| callnumber-sort | RS 3420 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | VS 5350 |
| ctrlnum | (OCoLC)169452881 (DE-599)BVBBV023481701 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| discipline_str_mv | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02297nam a2200625zc 4500</leader><controlfield tag="001">BV023481701</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100201 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080807s2008 ne d||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2007035586</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780123695208</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-0-1236-9520-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0123695201</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-1236-9520-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)169452881</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023481701</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">ne</subfield><subfield code="c">NL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS420</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kerns, Edward Harvel</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug-like properties: concepts, structure design and methods</subfield><subfield code="b">from ADME to toxicity optimization</subfield><subfield code="c">Edward H. Kerns and Li Di</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier, Academic Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIX, 526 S.</subfield><subfield code="b">graph. Darst.</subfield><subfield code="c">27 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 492) and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chimie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Conception</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Développement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Relations structure-activité</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Structure-activity relationships</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Toxicity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacokinetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Structure-Activity Relationship</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkungsmechanismus</subfield><subfield code="0">(DE-588)4292866-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Konzeption</subfield><subfield code="0">(DE-588)4204973-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Konzeption</subfield><subfield code="0">(DE-588)4204973-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Wirkungsmechanismus</subfield><subfield code="0">(DE-588)4292866-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Di, Li</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy0811/2007035586-d.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016663813</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV023481701 |
| illustrated | Illustrated |
| index_date | 2024-07-02T21:38:11Z |
| indexdate | 2024-07-09T21:19:46Z |
| institution | BVB |
| isbn | 9780123695208 0123695201 |
| language | English |
| lccn | 2007035586 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016663813 |
| oclc_num | 169452881 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-29 |
| owner_facet | DE-19 DE-BY-UBM DE-29 |
| physical | XIX, 526 S. graph. Darst. 27 cm |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Elsevier, Academic Press |
| record_format | marc |
| spelling | Kerns, Edward Harvel Verfasser aut Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization Edward H. Kerns and Li Di Amsterdam [u.a.] Elsevier, Academic Press 2008 XIX, 526 S. graph. Darst. 27 cm txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references (p. 492) and index Chimie pharmaceutique Médicaments - Conception Médicaments - Développement Médicaments - Relations structure-activité Pharmaceutical chemistry Drugs Structure-activity relationships Drug development Drugs Design Drug Design Drug Evaluation, Preclinical Drug Toxicity Pharmaceutical Preparations metabolism Pharmacokinetics Structure-Activity Relationship Wirkungsmechanismus (DE-588)4292866-7 gnd rswk-swf Konzeption (DE-588)4204973-8 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittel (DE-588)4003115-9 s Konzeption (DE-588)4204973-8 s Wirkungsmechanismus (DE-588)4292866-7 s 1\p DE-604 Di, Li Sonstige oth http://www.loc.gov/catdir/enhancements/fy0811/2007035586-d.html Publisher description 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Kerns, Edward Harvel Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization Chimie pharmaceutique Médicaments - Conception Médicaments - Développement Médicaments - Relations structure-activité Pharmaceutical chemistry Drugs Structure-activity relationships Drug development Drugs Design Drug Design Drug Evaluation, Preclinical Drug Toxicity Pharmaceutical Preparations metabolism Pharmacokinetics Structure-Activity Relationship Wirkungsmechanismus (DE-588)4292866-7 gnd Konzeption (DE-588)4204973-8 gnd Arzneimittel (DE-588)4003115-9 gnd |
| subject_GND | (DE-588)4292866-7 (DE-588)4204973-8 (DE-588)4003115-9 |
| title | Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization |
| title_auth | Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization |
| title_exact_search | Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization |
| title_exact_search_txtP | Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization |
| title_full | Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization Edward H. Kerns and Li Di |
| title_fullStr | Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization Edward H. Kerns and Li Di |
| title_full_unstemmed | Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization Edward H. Kerns and Li Di |
| title_short | Drug-like properties: concepts, structure design and methods |
| title_sort | drug like properties concepts structure design and methods from adme to toxicity optimization |
| title_sub | from ADME to toxicity optimization |
| topic | Chimie pharmaceutique Médicaments - Conception Médicaments - Développement Médicaments - Relations structure-activité Pharmaceutical chemistry Drugs Structure-activity relationships Drug development Drugs Design Drug Design Drug Evaluation, Preclinical Drug Toxicity Pharmaceutical Preparations metabolism Pharmacokinetics Structure-Activity Relationship Wirkungsmechanismus (DE-588)4292866-7 gnd Konzeption (DE-588)4204973-8 gnd Arzneimittel (DE-588)4003115-9 gnd |
| topic_facet | Chimie pharmaceutique Médicaments - Conception Médicaments - Développement Médicaments - Relations structure-activité Pharmaceutical chemistry Drugs Structure-activity relationships Drug development Drugs Design Drug Design Drug Evaluation, Preclinical Drug Toxicity Pharmaceutical Preparations metabolism Pharmacokinetics Structure-Activity Relationship Wirkungsmechanismus Konzeption Arzneimittel |
| url | http://www.loc.gov/catdir/enhancements/fy0811/2007035586-d.html |
| work_keys_str_mv | AT kernsedwardharvel druglikepropertiesconceptsstructuredesignandmethodsfromadmetotoxicityoptimization AT dili druglikepropertiesconceptsstructuredesignandmethodsfromadmetotoxicityoptimization |